The Ryder Picture Company, the production outfit behind Adam Wingard's desert-set action-horror film "Onslaught," is adopting a new identity. The banner has been rebranded as Embrace, a change that takes effect as the company looks to reposition itself following the September 2 release of its most recent feature.
The shift was confirmed exclusively to USA Film News. No details were provided regarding the reasoning behind the name change or whether the company's leadership structure would be affected.
"Onslaught," a 92-minute thriller that blends action and horror, arrived in theaters on September 2, 2026. Directed by Adam Wingard, the film follows a rogue squad of genetically engineered super soldiers who break loose in the desert, forcing a hardened Army sniper to unleash hell in order to protect her young daughter. The premise pairs a contained survival scenario with science-fiction elements, a combination that has characterized several of Wingard's prior projects.
A Cast Built for Genre Work
The film stars Adria Arjona as Celeste, the sniper at the center of the story. Arjona is joined by Dan Stevens as Dr. Hans Kammler, Eric Wareheim as Kovacks, Reginald VelJohnson as Josiah, Michael Biehn as Baylor, Blake Kennedy as Daisy, Alex Pereira as The Butcher, and Drew Starkey as Cyrus.
The ensemble reflects a mix of established genre veterans and newer faces. Biehn, whose filmography is closely associated with science-fiction and action cinema, appears as Baylor, while Pereira - known primarily for his career in mixed martial arts - takes on the role of The Butcher. Stevens, meanwhile, continues a run of roles that frequently place him in heightened, high-concept material.
Wingard directed from a screenplay whose details have not been publicly disclosed. The film's English-language production places it squarely within the Hollywood studio system, and its runtime of 92 minutes positions it as a lean, tightly paced entry in the action-horror space.
Reception and Rating
As of mid-September, "Onslaught" holds a TMDb rating of 6.1 out of 10, a middling score that suggests a divided response from audiences and critics alike. The rating is a snapshot rather than a definitive verdict, particularly for a genre film that opened less than two weeks ago and may continue to find viewers as word of mouth develops.
For the Ryder Picture Company - now Embrace - "Onslaught" represents the final release under the old banner. Whether the rebranding signals a broader creative pivot or is simply a corporate housekeeping matter remains unclear. Production companies frequently rebrand for reasons ranging from new financing partnerships to a desire to distance themselves from past associations, but no such specifics were offered in this instance.
What the Change Means
The timing is notable. Rebranding immediately after the release of a high-profile genre title could indicate that Embrace intends to build on the visibility "Onslaught" generated while shedding the name under which it was made. Alternatively, the move may have been in development for some time and is only now being made public.
What is clear is that Embrace inherits a slate that includes a film with a recognizable director, a cast with crossover appeal, and a premise that fits comfortably within the current appetite for grounded science-fiction thrillers. The company's next announcements will likely clarify its direction.
For now, "Onslaught" remains in theaters, carrying the Ryder Picture Company name in its credits - a last artifact of the banner that is no longer.
USA Film News will update this story as more information becomes available.
Source: The Hollywood Reporter
